title: In vitro and in vivo cholesterol lowering ability of Lactobacillus pentosus KF923750.
abstract: Lactobacillus pentosus KF923750 was characterised for probiotic related properties and then characterised for cholesterol uptake in vitro as well as in vivo using rabbits fed a high-cholesterol diet. The survival percentage of L. pentosus KF923750 was 100% at pH 3, 52.18% at pH 2 and 36.21% at pH 2 plus pepsin. Similarly, this strain appeared resistant to bile (0.1% [98.42%], 0.3% [88.52%], 0.5% [75.60%] and 1% [71.15%]), after 4 h exposure. Moreover, L. pentosus KF923750 controlled growth of Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 through the production of a bacteriocin-like inhibitory substance and anti-adhesive capabilities. L. pentosus KF923750 was non-cytotoxic to eukaryotic cells but sensitive to some antibiotics. Compared with rabbits fed a high-cholesterol diet but without L. pentosus KF923750 supplementation, the plasma total cholesterol, low-density lipoprotein cholesterol and triglycerides levels were significantly decreased in L. pentosus KF923750-fed rabbits by 11.54, 16.00 and 18.00%, respectively, with no significant change in high-density lipoprotein cholesterol levels. The histological sections of livers revealed lesions in all the rabbits that were fed a high-cholesterol diet, but these were less pronounced in rabbits ingesting L. pentosus KF923750. This study highlights the potential of lactobacilli, such as L. pentosus KF923750, in the treatment or prevention of hypercholesterolemia.
authors.affiliation: 1 Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria.
authors.forename: F
authors.initials: F
authors.lastname: Bendali
authors.affiliation: 1 Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria.
authors.forename: K
authors.initials: K
authors.lastname: Kerdouche
authors.affiliation: 1 Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria.
authors.forename: S
authors.initials: S
authors.lastname: Hamma-Faradji
authors.affiliation: 2 Institut Charles Viollette, Batiment Polytech-Lille, Cité scientifique, Avenue Paul Langevin, 59655 Villeneuve d'Ascq, France.
authors.forename: D
authors.initials: D
authors.lastname: Drider
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001430:Bacteriocins / Q000378:metabolism; D002460:Cell Line; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D059305:Diet, High-Fat; D004926:Escherichia coli / Q000254:growth & development; D006937:Hypercholesterolemia / Q000517:prevention & control* / Q000628:therapy*; D000070018:Lactiplantibacillus pentosus; D019936:Probiotics / Q000627:therapeutic use*; D011817:Rabbits; D013211:Staphylococcus aureus / Q000254:growth & development; D014280:Triglycerides / Q000097:blood*
chemical_list: D000924:Anticholesteremic Agents; D001430:Bacteriocins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides
keywords: Lactobacillus; antagonism; hypocholesterolemic effect; probiotics; rabbits